Comera Life Sciences Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/09/2023 | Q3 2023 | -$0.09 | $136,310 | |||
| 08/10/2023 | Q2 2023 | -$0.07 | $315,055 | |||
| 05/12/2023 | Q1 2023 | -$4.09 | $392,915 | |||
| 03/17/2023 | Q4 2022 | -$0.28 | $156,120 | |||
| 11/14/2022 | Q3 2022 | -$0.23 | $234,922 | |||
| 08/15/2022 | Q2 2022 | -$1.74 | $146,726 | |||
| 03/30/2022 | Q1 2022 | -$0.17 | $95,334 | |||
| 12/31/2021 | Q4 2021 | -$0.15 | $73,334 | |||
| 09/29/2021 | Q3 2021 | -$0.05 | $87,767 | |||
| 06/29/2021 | Q2 2021 | -$0.10 | $70,917 | |||
| 03/30/2021 | Q1 2021 | -$0.05 | $87,814 |
Comera Life Sciences Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Comera Life Sciences Holdings, Inc.'s earnings date?
Comera Life Sciences Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off last year's report dates.
-
How can I listen to Comera Life Sciences Holdings, Inc.'s earnings conference call?
The conference call for Comera Life Sciences Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Comera Life Sciences Holdings, Inc.'s conference call transcript?
The conference call transcript for Comera Life Sciences Holdings, Inc.'s latest earnings report can be read online.
-
How much revenue does Comera Life Sciences Holdings, Inc. generate each year?
Comera Life Sciences Holdings, Inc. (:CMRAW) has a recorded annual revenue of $633,102.
-
How much profit does Comera Life Sciences Holdings, Inc. generate each year?
Comera Life Sciences Holdings, Inc. (:CMRAW) has a recorded net income of $633,102. Comera Life Sciences Holdings, Inc. has generated $-2.3 earnings per share over the last four quarters.
-
What is Comera Life Sciences Holdings, Inc.'s price-to-earnings ratio?
Comera Life Sciences Holdings, Inc. (:CMRAW) has a price-to-earnings ratio of -5.69 and price/earnings-to-growth ratio is -0.16.
